Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-cgon
/
CG Oncology Inc
CGON
26.440
USD
+0.130
+0.49%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
2.02B
Market Cap
Loss
P/E TTM
CG Oncology Inc
26.440
+0.130
+0.49%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-12.55%
-29.28M
-28.65%
-20.66M
-29.82%
-15.92M
-49.45%
-16.12M
-225.72%
-26.01M
-135.19%
-16.06M
--
-12.26M
--
-10.79M
--
-7.99M
--
-6.83M
Net income from continuing operations
-103.47%
-34.45M
-97.31%
-31.80M
-73.39%
-20.41M
-62.73%
-18.90M
-95.36%
-16.93M
-92.04%
-16.12M
--
-11.77M
--
-11.62M
--
-8.67M
--
-8.39M
Operating gains losses
500.00%
24.00K
-100.00%
0.00
320.00%
21.00K
75.00%
7.00K
0.00%
4.00K
0.00%
4.00K
--
5.00K
--
4.00K
--
4.00K
--
4.00K
Other non-cash items
78.70%
-469.00K
143.27%
1.25M
-45.77%
-1.59M
-780.22%
-2.48M
-1861.60%
-2.20M
-2800.00%
-2.89M
--
-1.09M
--
364.00K
--
125.00K
--
107.00K
Change in working capital
105.58%
469.00K
126.46%
4.90M
1644.62%
3.40M
951.40%
3.01M
-2351.74%
-8.40M
65.80%
2.16M
--
195.00K
--
286.00K
--
373.00K
--
1.30M
-Change in receivables
--
436.00K
--
-644.00K
4600.00%
45.00K
--
-90.00K
--
--
--
--
--
-1.00K
--
--
--
--
--
--
-Change in prepaid expenses
82.63%
-982.00K
59.59%
-198.00K
76.84%
-431.00K
327.87%
1.21M
-2624.11%
-5.65M
-168.92%
-490.00K
--
-1.86M
--
-531.00K
--
224.00K
--
711.00K
-Change in other current assets
-6.06%
-35.00K
--
-41.00K
-100.00%
0.00
--
-1.00K
--
-33.00K
--
0.00
--
13.00K
--
0.00
--
0.00
--
0.00
Cash from non-recurring investing activities
Cash from operating activities
-12.55%
-29.28M
-28.65%
-20.66M
-29.82%
-15.92M
-49.45%
-16.12M
-225.72%
-26.01M
-135.19%
-16.06M
--
-12.26M
--
-10.79M
--
-7.99M
--
-6.83M
Investing cash flow
Net cash from continuing investing activities
33.33%
16.00K
--
209.00K
83.33%
-1.00K
133.33%
14.00K
--
12.00K
--
--
--
-6.00K
--
6.00K
--
0.00
--
-1.00K
Capital expenditures
33.33%
16.00K
--
209.00K
--
--
133.33%
14.00K
--
12.00K
--
--
--
--
--
6.00K
--
0.00
--
--
Net cash flow from disposal of fixed assets
33.33%
16.00K
--
209.00K
83.33%
-1.00K
133.33%
14.00K
--
12.00K
--
--
--
-6.00K
--
6.00K
--
0.00
--
-1.00K
Net cash flow from investment products
47.39%
-161.75M
-34.40%
11.11M
119.83%
32.00M
-135.04%
-36.22M
-290.64%
-307.43M
130.62%
16.94M
--
-161.39M
--
103.36M
--
-78.70M
--
-55.34M
Net cash flow from other investing activities
--
-25.00M
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Cash from non-current investing activities
Net cash flow from investing activities
39.25%
-186.77M
-35.64%
10.90M
119.83%
32.01M
-135.05%
-36.23M
-290.66%
-307.44M
130.62%
16.94M
--
-161.39M
--
103.36M
--
-78.70M
--
-55.34M
Financing cash flow
Cash flow from continuous financing activities
-99.89%
450.00K
7833.26%
223.41M
-97.95%
2.17M
100.26%
40.00K
52735.03%
402.66M
-105.10%
-2.89M
--
105.88M
--
-15.22M
--
-765.00K
--
56.70M
Net cash flow from debt Issuance/repayment
100.00%
0.00
100.00%
0.00
100.00%
0.00
100.00%
0.00
56.18%
-365.00K
--
-1.00K
--
-61.00K
--
-15.39M
--
-833.00K
--
--
Net cash flow from common stock issuance/repurchase
-100.00%
0.00
--
223.06M
--
0.00
--
0.00
--
406.41M
--
--
--
0.00
--
0.00
--
0.00
--
--
Net cash flow from preferred stock issuance/repurchase
--
--
--
--
-100.00%
0.00
--
--
--
--
-100.00%
2.00K
--
104.63M
--
--
--
--
--
56.55M
Proceeds from stock option exercised by employees
--
682.00K
36.02%
355.00K
36.55%
2.17M
-53.33%
77.00K
-100.00%
0.00
76.35%
261.00K
--
1.59M
--
165.00K
--
68.00K
--
148.00K
Net cash flow from other financing activities
93.15%
-232.00K
100.00%
0.00
100.00%
0.00
--
-37.00K
--
-3.39M
--
-3.15M
--
-270.00K
--
0.00
--
0.00
--
--
Net cash from non-recurrent financing activities
Net cash from financing activities
-99.89%
450.00K
7833.26%
223.41M
-97.95%
2.17M
100.26%
40.00K
52735.03%
402.66M
-105.10%
-2.89M
--
105.88M
--
-15.22M
--
-765.00K
--
56.70M
Net cash flow
Beginning cash balance
3009.94%
257.07M
322.57%
43.41M
-67.76%
25.16M
11078.64%
77.47M
-90.62%
8.27M
-89.03%
10.27M
--
78.04M
--
693.00K
--
88.14M
--
93.61M
Current period cash flow changes
-411.55%
-215.60M
10745.59%
213.66M
126.94%
18.25M
-167.63%
-52.31M
179.13%
69.20M
63.30%
-2.01M
--
-67.77M
--
77.35M
--
-87.45M
--
-5.47M
Ending cash balance
-46.47%
41.47M
3009.94%
257.07M
322.57%
43.41M
-67.76%
25.16M
11078.64%
77.47M
-90.62%
8.27M
--
10.27M
--
78.04M
--
693.00K
--
88.14M
Free cash flow
-12.56%
-29.29M
-29.95%
-20.87M
--
--
-49.50%
-16.13M
-225.87%
-26.02M
--
-16.06M
--
--
--
-10.79M
--
-7.99M
--
--
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up